Sponsoring Agency HHS
    POP 9/20/12 - 11/9/15 (3 years)


Department of Health and Human Services, National Institutes of Health (NIH), National Cancer Institute (NCI) has awarded a Master IDIQ to support the conduct of toxicological and pharmacological evaluations of potential cancer preventive agents for Investigational New Drug (IND) applications to the Food and Drug Administration (FDA) for phase 0, 1-3 clinical studies; New Drug Applications (NDA) to the FDA; and to determine appropriate first-in-human (FIH) doses.

  • $935.7k Aggregate Dollars Obligated
  • $935.7k Aggregate Base & Exercised Options
  • $935.7k Aggregate Base & All Options (Ceiling)

Market Stats Related Contracts